SCPS OTC
Scopus BioPharma Inc.
1W: +0.0%
1M: +0.0%
3M: -20.0%
YTD: +0.0%
1Y: +33.3%
3Y: -99.1%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±30.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$12M
+57.6% ▲
Net Income
-$12M
+58.1% ▲
EPS (Diluted)
$-0.55
+65.8% ▲
EBITDA
-$12M
+55.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $278K | $463K | $7M | $15M | $3M |
| SG&A Expenses | $408K | $2M | $3M | $13M | $9M |
| Operating Expenses | $686K | $3M | $10M | $28M | $12M |
| Operating Income | -$686K | -$3M | -$10M | -$28M | -$12M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $706K | $775K | $0 |
| Income Before Tax | -$686K | -$3M | -$11M | -$27M | -$12M |
| Tax Expense | $0 | $0 | $706K | $775K | -$105K |
| Net Income | -$686K | -$3M | -$12M | -$28M | -$12M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.05 | $-0.18 | $-0.87 | $-1.61 | $-0.55 |
| EBITDA | -$686K | -$3M | -$10M | -$26M | -$12M |
| Shares Outstanding | 15M | 15M | 13M | 17M | 21M |